PH25903A - Pyridine derivatives and their use as nootropic agents - Google Patents

Pyridine derivatives and their use as nootropic agents

Info

Publication number
PH25903A
PH25903A PH36520A PH36520A PH25903A PH 25903 A PH25903 A PH 25903A PH 36520 A PH36520 A PH 36520A PH 36520 A PH36520 A PH 36520A PH 25903 A PH25903 A PH 25903A
Authority
PH
Philippines
Prior art keywords
pyridine derivatives
nootropic agents
nootropic
agents
pyridine
Prior art date
Application number
PH36520A
Other languages
English (en)
Inventor
Georg Von Sprecher
Peter Waldmeier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PH25903A publication Critical patent/PH25903A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH36520A 1986-03-17 1988-02-17 Pyridine derivatives and their use as nootropic agents PH25903A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH108486 1986-03-17
CH226986 1986-06-04

Publications (1)

Publication Number Publication Date
PH25903A true PH25903A (en) 1991-12-19

Family

ID=25686601

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36520A PH25903A (en) 1986-03-17 1988-02-17 Pyridine derivatives and their use as nootropic agents

Country Status (18)

Country Link
US (1) US4863938A (ko)
EP (1) EP0239533B1 (ko)
JP (1) JPH0662566B2 (ko)
KR (1) KR910000658B1 (ko)
AU (1) AU601401B2 (ko)
CA (1) CA1312869C (ko)
DE (1) DE3781705D1 (ko)
DK (1) DK170334B1 (ko)
ES (1) ES2052601T3 (ko)
FI (1) FI86634C (ko)
GR (1) GR3006476T3 (ko)
HU (1) HU201913B (ko)
IE (1) IE59812B1 (ko)
IL (1) IL81903A0 (ko)
NO (1) NO172984C (ko)
NZ (1) NZ219629A (ko)
PH (1) PH25903A (ko)
PT (1) PT84490B (ko)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073851A (en) * 1957-12-04 1963-01-15 Hoffmann La Roche Formamidines of primary amines
NL253634A (ko) * 1959-07-10
US3184482A (en) * 1961-11-20 1965-05-18 Hoffmann La Roche Anthraquinone formamidines of primary amines
US3182053A (en) * 1961-11-20 1965-05-04 Hoffmann La Roche Pyridine formamidines of primary amines
US3133078A (en) * 1961-11-20 1964-05-12 Hoffmann La Roche Oxazole formamidines of primary amines
GB1256714A (ko) * 1968-06-27 1971-12-15
US4186264A (en) * 1976-04-20 1980-01-29 Pfizer Inc. Triazapentadienes as acaricides
US4128652A (en) * 1976-04-20 1978-12-05 Pfizer Inc. Triazapentadienes as acaricides

Also Published As

Publication number Publication date
JPH0662566B2 (ja) 1994-08-17
CA1312869C (en) 1993-01-19
US4863938A (en) 1989-09-05
IE870687L (en) 1987-09-17
NO871075D0 (no) 1987-03-16
NZ219629A (en) 1990-03-27
AU601401B2 (en) 1990-09-13
DK133687D0 (da) 1987-03-16
NO172984C (no) 1993-10-06
PT84490A (en) 1987-04-01
PT84490B (pt) 1989-11-10
ES2052601T3 (es) 1994-07-16
HUT43823A (en) 1987-12-28
JPS62226959A (ja) 1987-10-05
NO871075L (no) 1987-09-18
FI871126A0 (fi) 1987-03-13
FI86634B (fi) 1992-06-15
DK133687A (da) 1987-09-18
DK170334B1 (da) 1995-08-07
FI871126A (fi) 1987-09-18
EP0239533A1 (de) 1987-09-30
KR910000658B1 (ko) 1991-01-31
KR870008850A (ko) 1987-10-21
FI86634C (fi) 1992-09-25
NO172984B (no) 1993-06-28
IE59812B1 (en) 1994-04-06
HU201913B (en) 1991-01-28
DE3781705D1 (de) 1992-10-22
IL81903A0 (en) 1987-10-20
EP0239533B1 (de) 1992-09-16
GR3006476T3 (ko) 1993-06-21
AU7007087A (en) 1987-09-24

Similar Documents

Publication Publication Date Title
PH23081A (en) Avermectin derivatives and the use thereof as antiparasitic agents
IL81789A0 (en) Pyridine sulfonamides and their use as herbicides
ZA875671B (en) Titanocenes and their use
AR242573A1 (es) Procedimiento para preparar tetrazolil fenoxialquilisoxazoles sustituidos.
PH23785A (en) Nucleosides and their use as anti-neoplastic agents
EP0256981A3 (en) Titanocenes and their use
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
EG19184A (en) 4-Nitro-n- phenylpyrazole derivatives and their use as pesticide
PH24904A (en) N-substituted-arylalkyl and arylalkylene aminoheterocyclics as antisectory agents
PH24714A (en) Poly-4-aminopyrrole-2-carbosamido derivatives and their use as antiviral or antitumos agents
ZA874727B (en) S-trifluorobutenyl derivatives and pesticidal uses
EG18368A (en) Benzoyl-urea derivatives and its use as pesticide
EP0255801A3 (en) Anilinotriazines and their use
ZA873879B (en) Pest-combating agents based on aminopyrimidine derivatives and novel aminopyrimidine compounds
IL82798A0 (en) Substituted 3-amino-2-benzoyl-cyclohex-2-enones and their use as herbicides
ZA879235B (en) Peridone derivatives,and their preparation and use
NZ221401A (en) Pyridine derivatives and growth-promoting compositions
EP0238357A3 (en) 1,2,4-triazinone derivatives, their preparation and use
ZA885329B (en) Hydroxyethylazole derivatives and their use as fungicides
EP0163238A3 (en) Substituted and bridged pyridines useful as pharmaceutical agents
PH25903A (en) Pyridine derivatives and their use as nootropic agents
GB8700115D0 (en) Proline derivatives
GB2204791B (en) Nootropic agent
ZA87504B (en) Pyridine derivatives
GB2135302B (en) Substituted cyclohexenyl-ethanol derivatives and their use as smoke-flavour modifying agents